Hologic Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Okay. Thanks, everyone, for joining us this afternoon. The last meeting for the day, but certainly should be an exciting one, given all the diagnostic commentary we've heard in the past 2 days.
We have Hologic with us. Representing the company, we have our CFO, Karleen Oberton and Mike Watts from Investor Relations as well with us. Mike is from sunny San Diego. So he's looking good. Well, maybe Karleen, I want to start off with just looking at what the stock has done in this year.I mean these numbers you guys have put up it's -- I mean, truly astounding. Yet the shares have been range bound. There is a debate on sustainability, what's the base business work, is COVID just a one-off? And what happens when those revenues eventually do fall off?
So let's start with the sustainability side, talk to us on -- Q4 was strong for you guys, your fiscal Q4 ending September. How has the second wave impacted your business so far as you look at your fiscal Q1 and perhaps after the March quarter?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |